Preventive Misconception and Risk Behaviors in a Multinational HIV Prevention Trial.

ABSTRACT:

Background

Some HIV prevention research participants may hold a "preventive misconception" (PM), an overestimate of the probability or level of personal protection afforded by trial participation. However, these reports typically rely upon small, retrospective qualitative assessments that did not use a standardized approach.

Methods

We administered a measure of PM called PREMIS, during Microbicide Trials Network 020-A Study to Prevent Infection with a Ring for Extended Use, a large, multicenter, placebo-controlled, phase III trial evaluating the safety and efficacy of a dapivirine vaginal ring among women at risk for HIV infection in Malawi, South Africa, Uganda, and Zimbabwe. The maximum follow-up period was 2.6 years.

Results

One thousand two hundred sixty-one respo

SUBMITTER: Sugarman J 

PROVIDER: S-EPMC6612263 | biostudies-literature | 2019 Apr-Jun

REPOSITORIES: biostudies-literature